Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease

Passive Immunotherapies Protect WRvFire and IHD-J-Luc Vaccinia Virus-Infected Mice from Lethality by Reducing Viral Loads in the Upper Respiratory Tract and Internal Organs

(2011) M. Zaitseva et al.   JOURNAL OF VIROLOGY

Postexposure Prevention of Progressive Vaccinia in SCID Mice Treated with Vaccinia Immune Globulin

(2010) R. W. Fisher et al.   Clinical and Vaccine Immunology

Safety of intravenous immunoglobulin treatment

(2010) James B Caress et al.   Expert Opinion On Drug Safety

Capturing the Natural Diversity of the Human Antibody Response against Vaccinia Virus

(2010) J. Lantto et al.   JOURNAL OF VIROLOGY

Protection against Lethal Vaccinia Virus Challenge by Using an Attenuated Matrix Protein Mutant Vesicular Stomatitis Virus Vaccine Vector Expressing Poxvirus Antigens

(2010) C. L. Braxton et al.   JOURNAL OF VIROLOGY

Human cowpox in a veterinary student

(2010) Martin Glatz et al.   LANCET INFECTIOUS DISEASES

A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge

(2010) George W. Buchman et al.   VACCINE

VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone

(2010) Leonard Moise et al.   VACCINE

Application of Bioluminescence Imaging to the Prediction of Lethality in Vaccinia Virus-Infected Mice

(2009) M. Zaitseva et al.   JOURNAL OF VIROLOGY

Heavily Isotype-Dependent Protective Activities of Human Antibodies against Vaccinia Virus Extracellular Virion Antigen B5

(2009) M. R.-E.-I. Benhnia et al.   JOURNAL OF VIROLOGY

Antigen-specific human polyclonal antibodies from hyperimmunized cattle

(2009) Yoshimi Kuroiwa et al.   NATURE BIOTECHNOLOGY

Overview, Prevention, and Treatment of Rabies

(2009) Andrea Julia Nigg et al.   PHARMACOTHERAPY

Zoonotic poxviruses

(2009) Sandra Essbauer et al.   VETERINARY MICROBIOLOGY

The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination

(2008) Ren-Huan Xu et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Vaccination of BALB/c Mice with Escherichia coli-Expressed Vaccinia Virus Proteins A27L, B5R, and D8L Protects Mice from Lethal Vaccinia Virus Challenge

(2008) A. Berhanu et al.   JOURNAL OF VIROLOGY

Differential Antigen Requirements for Protection against Systemic and Intranasal Vaccinia Virus Challenges in Mice

(2008) D. R. Kaufman et al.   JOURNAL OF VIROLOGY

Redundancy and Plasticity of Neutralizing Antibody Responses Are Cornerstone Attributes of the Human Immune Response to the Smallpox Vaccine

(2008) M. R.-E.-I. Benhnia et al.   JOURNAL OF VIROLOGY

Vaccinia Virus Extracellular Enveloped Virion Neutralization In Vitro and Protection In Vivo Depend on Complement

(2008) M. R.-E.-I. Benhnia et al.   JOURNAL OF VIROLOGY

Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies

(2008) Joseph W. Golden et al.   VACCINE

Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine

(2008) Joseph W. Golden et al.   VIROLOGY